<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[GenVec Inc. | Company News & Executive Profiles - GNVC | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/genvec+inc..html?i=11]]></link>
	<description><![CDATA[Latest company news & analysis, recent events, stock quotes, earning call transcripts, with profiles and descriptions of top business executives for GenVec Inc.]]></description>
	<s:counts start="0" returned="10" found="20" />
	<language>en-us</language>
	<item>
		<title><![CDATA[GenVec, Inc. Q2 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-224340.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Thank you. [Operator instructions]. Your first question comes from the line of Debjit Chattopadhyay with Boenning & Scattergood. Please proceed. Debjit Chattopadhyay Hi, good morning gentlemen and thank you for taking the question. Douglas Swirsky  Good morning. Debjit Chattopadhyay  Given your stated position that you...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Fri, 08 Aug 2008 08:46:13 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/genvec+inc..html"><![CDATA[GenVec Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GNVC</category>
		<category domain="tickers">GNVC</category>
	</item>
	<item>
		<title><![CDATA[GenVec Receives Continued Funding from the U.S. Department of Homeland Security for Vaccine Program]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_July_29/ai_n27950496]]></link>
		<description><![CDATA[GAITHERSBURG, Md. -- GenVec, Inc. (Nasdaq:GNVC) announced today that the U.S. Department of Homeland Security DHS has executed the second option period under a three-year agreement with GenVec to support the development of vaccines for the prevention of foot-and-mouth disease FMD. GenVec will receive up to $6.6 million to complete...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 29 Jul 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/genvec+inc..html"><![CDATA[GenVec Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[HEALTHCARE]]></category>
		<category domain="http://resources.bnet.com/topic/u.s.+department+of+homeland+security.html"><![CDATA[U.S. Department of Homeland Security]]></category>
		<category domain="http://resources.bnet.com/topic/vaccine.html"><![CDATA[vaccine]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GNVC</category>
		<category domain="tickers">GNVC</category>
	</item>
	<item>
		<title><![CDATA[Encouraging Findings from TNFerade&#153; Head and Neck Cancer Study Presented at ASCO]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_May_31/ai_n25470563]]></link>
		<description><![CDATA[Data Support Continued Development of TNFerade in Head and Neck Cancer  GAITHERSBURG, Md. -- Encouraging data from GenVec, Inc.'s (Nasdaq:GNVC) Phase I clinical trial of TNFerade[TM] in patients with head and neck cancer were presented by study investigator Everett Vokes, M.D., University of Chicago, in a poster session at...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Sat, 31 May 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/genvec+inc..html"><![CDATA[GenVec Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[HEALTHCARE]]></category>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[patient]]></category>
		<category domain="http://resources.bnet.com/topic/sec.html"><![CDATA[SEC]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GNVC</category>
		<category domain="tickers">GNVC</category>
	</item>
	<item>
		<title><![CDATA[GenVec, Inc. Q1 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-227149.html]]></link>
		<description><![CDATA[ Question-and-Answer Session Operator Operator instructions Our first question is from Debjit Chattopadhyay with Boenning. 	 Debjit Chattopadhyay &#8211; Boenning  Hi good morning gentleman, thank you for taking the question. Hey Dough, a question for you; what was the average take down price for &#8211; when you access the...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Fri, 09 May 2008 09:58:09 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/genvec+inc..html"><![CDATA[GenVec Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GNVC</category>
		<category domain="tickers">GNVC</category>
	</item>
	<item>
		<title><![CDATA[ENG, EPIX, GETI, GLAD, GMXR, GNVC Have Also Been Added To Naked Short List Today.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5243/is_200804/ai_n25270712]]></link>
		<description><![CDATA[M2 PRESSWIRE-2 April 2008-BUYINS.NET: ENG, EPIX, GETI, GLAD, GMXR,  GNVC Have Also Been Added To Naked Short List TodayC1994-2008 M2  COMMUNICATIONS LTD    RDATE:02042008    BUYINS.NET, www.buyins.net, announced today that these select  companies have been added to the NASDAQ, AMEX and NYSE naked...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 02 Apr 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/genvec+inc..html"><![CDATA[GenVec Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[HEALTHCARE]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/sec.html"><![CDATA[SEC]]></category>
		<category domain="http://resources.bnet.com/topic/stock.html"><![CDATA[stock]]></category>
		<category domain="http://resources.bnet.com/topic/vaccine.html"><![CDATA[vaccine]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GNVC</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="tickers">GNVC,NDAQ</category>
	</item>
	<item>
		<title><![CDATA[GenVec Inc. Q4 2007 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-229173.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Operator Instructions. And your first question comes from the line of [Sean Wu of Rodman & Renshaw]. Please proceed. Sean Wu - Rodman & Renshaw Hello, good morning. Paul Fischer Good morning. Sean Wu - Rodman & Renshaw  Thank you for taking my question. I had...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Fri, 14 Mar 2008 11:31:09 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/genvec+inc..html"><![CDATA[GenVec Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GNVC</category>
		<category domain="tickers">GNVC</category>
	</item>
	<item>
		<title><![CDATA[Emerging Markets Consulting, LLC. : Emerging Equity Alerts.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5243/is_200801/ai_n25238160]]></link>
		<description><![CDATA[M2 PRESSWIRE-7 January 2008-Emerging Markets Consulting, LLC.:  Emerging Markets Consulting, LLC. : Emerging Equity AlertsC1994-2008  M2 COMMUNICATIONS LTD     RDATE:07012008     Orlando, FL -- Stocks gaining traction in last Friday's  trading were North Pointe Holdings Corporation, (NASDAQ: NPTE), GenVec,  Inc.,...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 07 Jan 2008 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/consulting.html"><![CDATA[consulting]]></category>
		<category domain="http://resources.bnet.com/topic/equity.html"><![CDATA[equity]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/gene.html"><![CDATA[gene]]></category>
		<category domain="http://resources.bnet.com/topic/genvec+inc..html"><![CDATA[GenVec Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[HEALTHCARE]]></category>
		<category domain="http://resources.bnet.com/topic/infosys+technologies+ltd..html"><![CDATA[Infosys Technologies Ltd.]]></category>
		<category domain="http://resources.bnet.com/topic/insurance.html"><![CDATA[Insurance]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/vaccine.html"><![CDATA[vaccine]]></category>
		<category domain="http://resources.bnet.com/topic/xethanol+corp..html"><![CDATA[Xethanol Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GNVC</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">INFY</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">XNL</category>
		<category domain="tickers">GNVC,INFY,NDAQ,XNL</category>
	</item>
	<item>
		<title><![CDATA[GenVec Q3 2007 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-231934.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Operator Instructions And your first question comes from the line of Debjit Chattopadhyay from Boenning & Scattergood. Please proceed, sir. Debjit Chattopadhyay - Boenning & Scattergood Good afternoon, gentlemen. Douglas Swirsky Hello. Paul Fischer Hi, Debjit. Debjit Chattopadhyay - Boenning & Scattergood First question is regarding the...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Wed, 07 Nov 2007 17:53:11 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://resources.bnet.com/topic/genvec+inc..html"><![CDATA[GenVec Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GNVC</category>
		<category domain="tickers">GNVC</category>
	</item>
	<item>
		<title><![CDATA[GenVec Named to Deloitte's Technology Fast 50 for Maryland]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2007_Oct_3/ai_n27394704]]></link>
		<description><![CDATA[GAITHERSBURG, Md. -- GenVec, Inc. (Nasdaq: GNVC) has been named one of Maryland's fifty fastest growing technology, media, telecommunications and life science companies by Deloitte & Touche USA LLP, one of the nation's leading professional services organizations. Rankings in Deloitte's Technology Fast 50 Program are based on the percentage revenue...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 03 Oct 2007 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/deloitte+touche+tohmatsu.html"><![CDATA[Deloitte Touche Tohmatsu]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/genvec+inc..html"><![CDATA[GenVec Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[HEALTHCARE]]></category>
		<category domain="http://resources.bnet.com/topic/maryland.html"><![CDATA[Maryland]]></category>
		<category domain="http://resources.bnet.com/topic/technology.html"><![CDATA[Technology]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GNVC</category>
		<category domain="tickers">GNVC</category>
	</item>
	<item>
		<title><![CDATA[Harold R. Werner to Resign from GenVec's Board of Directors]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2007_Sept_21/ai_n27382628]]></link>
		<description><![CDATA[GAITHERSBURG, Md. -- GenVec, Inc. (Nasdaq:GNVC) announced today that Harold R. Werner, a member of the GenVec Board of Directors since January 2002, will be leaving the Board, effective September 30, 2007.  Mr. Werner is leaving to focus his attention on HealthCare Ventures' earlier-stage portfolio companies. "It has been...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 21 Sep 2007 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/board.html"><![CDATA[board]]></category>
		<category domain="http://resources.bnet.com/topic/financial.html"><![CDATA[financial]]></category>
		<category domain="http://resources.bnet.com/topic/genvec+inc..html"><![CDATA[GenVec Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[HEALTHCARE]]></category>
		<category domain="http://resources.bnet.com/topic/sec.html"><![CDATA[SEC]]></category>
		<category domain="http://resources.bnet.com/topic/vaccine.html"><![CDATA[vaccine]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GNVC</category>
		<category domain="tickers">GNVC</category>
	</item>
</channel>
</rss>
